Medicare Enrolled

Melissa Summerlin, NP-C

Nurse Practitioner - Adult Health · Gainesville, GA
1240 JESSE JEWELL PKWY SE STE 500, Gainesville, GA 30501
7705369864
Registered in NPPES since 2011
NPI: 1043519671 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Summerlin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Summerlin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Summerlin

Melissa Summerlin is a nurse practitioner - adult health in Gainesville, GA, with 15 years of NPI registration.

Between the years covered by Open Payments, Summerlin received a total of $5,010 from 58 pharmaceutical and/or device companies across 250 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Summerlin is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration $5,010 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,010
Total received (2021-2024)
Avg $1,253/year across 4 years
Top 8% in GA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
250
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,516
2023
$1,396
2022
$958
2021
$1,141

Payments by company (2024)

Celgene Corporation
$242
PFIZER INC.
$163
ABBVIE INC.
$114
Myriad Genetic Laboratories, Inc.
$110
AstraZeneca Pharmaceuticals LP
$108
Regeneron Healthcare Solutions, Inc.
$84
Janssen Biotech, Inc.
$76
Daiichi Sankyo Inc.
$66
Incyte Corporation
$52
Eisai Inc.
$50
SOBI, INC
$45
Novartis Pharmaceuticals Corporation
$43
E.R. Squibb & Sons, L.L.C.
$41
Gilead Sciences, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$28
Sumitomo Pharma America, Inc.
$25
BeiGene USA, Inc.
$21
Rigel Pharmaceuticals, Inc.
$21
GlaxoSmithKline, LLC.
$21
Mirati Therapeutics, Inc.
$20
Alexion Pharmaceuticals, Inc.
$20
Immunocore Limited
$19
SERVIER PHARMACEUTICALS LLC
$19
Exelixis Inc.
$19
Karyopharm Therapeutics Inc.
$18
Agios Pharmaceuticals, Inc.
$16
Coherus Biosciences Inc.
$15
Genentech USA, Inc.
$14
ARRAY BIOPHARMA INC
$12
Top 3 companies account for 34.3% of 2024 payments
All-time payments by company (2021-2024) ›
Celgene Corporation
$600
AstraZeneca Pharmaceuticals LP
$312
Seagen Inc.
$297
Janssen Biotech, Inc.
$259
E.R. Squibb & Sons, L.L.C.
$234
PFIZER INC.
$219
Eisai Inc.
$206
Incyte Corporation
$200
Novartis Pharmaceuticals Corporation
$196
Regeneron Healthcare Solutions, Inc.
$182
Daiichi Sankyo Inc.
$167
GENZYME CORPORATION
$153
GlaxoSmithKline, LLC.
$150
ABBVIE INC.
$114
Myriad Genetic Laboratories, Inc.
$110
Amgen Inc.
$106
AbbVie Inc.
$105
JAZZ PHARMACEUTICALS INC.
$103
Genentech USA, Inc.
$91
Gilead Sciences, Inc.
$84
Astellas Pharma US Inc
$77
Ipsen Biopharmaceuticals, Inc
$72
Karyopharm Therapeutics Inc.
$60
Blueprint Medicines Corporation
$56
ARRAY BIOPHARMA INC
$55
Coherus Biosciences Inc.
$51
SOBI, INC
$45
Takeda Pharmaceuticals U.S.A., Inc.
$45
Rigel Pharmaceuticals, Inc.
$43
BeiGene USA, Inc.
$41
Epizyme, Inc.,
$35
Alexion Pharmaceuticals, Inc.
$34
PUMA BIOTECHNOLOGY, INC.
$31
TAIHO ONCOLOGY, INC.
$28
Genmab U.S., Inc.
$26
Sumitomo Pharma America, Inc.
$25
Taiho Oncology, Inc.
$25
EISAI INC.
$23
Dova Pharmaceuticals
$22
Adaptive Biotechnologies Corporation
$20
Stemline Therapeutics Inc.
$20
TerSera Therapeutics LLC
$20
Mirati Therapeutics, Inc.
$20
Immunocore Limited
$19
SERVIER PHARMACEUTICALS LLC
$19
Exelixis Inc.
$19
Aveo Pharmaceuticals, Inc.
$18
Puma Biotechnology, Inc.
$18
ADC Therapeutics America, Inc.
$18
AVEO Pharmaceuticals, Inc.
$17
TOLMAR Pharmaceuticals, Inc.
$17
MorphoSys, US Inc.
$16
Kite Pharma, Inc.
$16
Agios Pharmaceuticals, Inc.
$16
Merck Sharp & Dohme Corporation
$16
Acceleron Pharma, Inc.
$15
PharmaEssentia USA Corporation
$13
Lilly USA, LLC
$11
Top 3 companies account for 24.1% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AYVAKIT · BESREMI · BLENREP · BRAFTOVI · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · DARZALEX · Doptelet · ELIGARD · ELREXFIO · ENHERTU · EPKINLY · Enhertu · Epkinly · FOTIVDA · FRUZAQLA · GAVRETO · Halaven · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MYRISK · NERLYNX · NINLARO · Nplate · OJJAARA · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · REBLOZYL · Reblozyl · Rezlidhia · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · TAGRISSO · TAZVERIK · TUKYSA · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VONJO · Venclexta · XOSPATA · XPOVIO · XTANDI · Xermelo · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Gainesville?
Compare adult-health nurse practitioners in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
48
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Summerlin is a nurse practitioner - adult health, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Summerlin receive payments from pharmaceutical companies?
Yes. Summerlin received a total of $5,010 from 58 companies across 250 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Summerlin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Adult-Health Nurse Practitioners in Gainesville
Browse adult-health nurse practitioners in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Adult-Health Nurse Practitioners in GA
Adult-health nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Adult-Health Nurse Practitioners in GA
Which GA adult-health nurse practitioners receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Seagen Inc. Payments to Doctors
See all physicians who received payments from Seagen Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →